Therapeutic effects of HESA-A (a herbal-marine compound) in acute organophosphorus pesticide poisoning

Publish Year:

1399

نوع سند:

مقاله ژورنالی

زبان:

English

View:

279

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_AJP-10-3_003

تاریخ نمایه سازی: 31 تیر 1399

Abstract:

Objective: Organophosphorus compounds (OPs) are common causes of poisonings. Atropine and oximes are pharmacological antidotes of OPs. However, because of their adverse effects and insufficient performance, several other compounds have been evaluated as adjuvant therapy. HESA-A is a herbal-marine drug that contains material from Carum carvi (Persian cumin), Penaeus latisculatus (king prawn), and Apium graveolens (celery) with anti-inflammatory and antioxidants properties, which has shown useful effects as adjuvant therapy on some diseases. We have evaluated the effect of HESA-A on 69 moderate to severe acute OPs poisoned patients (44 HESA-A treated and 25 controls) as an adjuvant drug. Materials and Methods: Two randomized age and sex matched groups of OPs poisoned patients were treated in Medical Toxicology Center of Imam Reza hospital, Mashhad, by conventional therapy with or without HESA-A (50 mg/kg/day orally). The evaluation criteria were total administrated doses of atropine and pralidoxime, intensive care unit (ICU) admission rate, mechanical respiration need, number of hospitalization days and mortality. Results: There were no significant differences between the morbidity and mortality rate criteria of the two groups; moreover, we did not observe significant adverse effects for HESA-A. Conclusion: HESA-A did not reduce morbidity and mortality of OPs poisoning and did not induce any major side effect in the patients.

Authors

Seyed RezaMousavi
Seyed Reza Mousavi

Medical Toxicology Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

MohammadMoshiri
Mohammad Moshiri

Medical Toxicology Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

EmadodinDarchini-Maragheh
Emadodin Darchini-Maragheh

Cutaneous Leishmaniasis Research Center, Emam Reza Hospital, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Seyed KhosroGhasempouri
Seyed Khosro Ghasempouri

Department of Forensic Medicine and Toxicology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Abbasi MM, Helli S, Monfaredan A, Jahanban-Esfahlan R. 2015a. Hesa-A ...
  • Abbasi MM, Mehdipour M, Monfaredan A, Jahanban-Esfahlan R. 2015b. Hesa-A ...
  • Abdollahi M, Jalali N, Sabzevari O, Hoseini R, Ghanea T. ...
  • Afshari R, Majdzadeh R, Balali-Mood M. 2004. Pattern of acute ...
  • Ahmadi A, Mohagheghi M, Karimi M, Seyed Ali G, Naseri ...
  • Ahmadi A, Mohagheghi M, Karimi M, Golestanha SA, Naseri M, ...
  • Ahmadi A, Barikbin B, Naseri M, Mohagheghi M. The effect ...
  • Ahmadi A, Naderi G, Asgary S. 2005a. Evaluation of hepatoprotective ...
  • Ahmadi A, Mohagheghi MA, Fazeli MS, Nahavandian B, Bashardoost N, ...
  • Alizadeh AM, Ahmadi A, Paknejad M, Mohammadzadeh M, Mohagheghi M. ...
  • Amitai G, Adani R, Fishbein E, Meshulam H, Laish I, ...
  • Balali-Mood M, Saber H. 2012. Recent advances in the treatment ...
  • Balali-Mood M, Ayati MH, Ali-Akbarian H. 2005. Effect of high ...
  • Banks CN, Lein PJ. 2012. A review of experimental evidence ...
  • Barikbin B, Qeisari M, Saeedi M, Esmailiazad M, Moravvej H, ...
  • Basher A, Rahman SH, Ghose A, Arif SM, Faiz MA, ...
  • Bertolote JM, Fleischmann A, Eddleston M, Gunnell D. 2006. Deaths ...
  • El-Shenawya NS, El-Salmyb F, Al-Eisab RA, El-Ahmaryb B. 2010. Amelioratory ...
  • Etemad L, Moshiri M, Balali-mood M. 2015. Chronic toxicity of ...
  • Fattahi S, Vosough Hosseini S, Aghbali AA, Mehdipour M, Helli ...
  • Mehrbod P, Ideris A, Rahman Omar A, Hair-Bejo M. 2014. ...
  • Moallem SA, Ahmadi A, Moshafi M, Taghavi MM. 2010. Teratogenic ...
  • Moallem SA, Ahmadi A, Moshafi M, Taghavi MM. 2011. Teratogenic ...
  • Moshiri M, Darchini-Maragheh E, Balali-Mood M. 2012. Advances in toxicology ...
  • Moshiri M, Alizadeh A, Balali-mood M, 2015. Clinical management of ...
  • Moshiri M, Vahabzadeh M, Etemad L, Hosseinzadeh H. 2013. Failure ...
  • Muhammadnejad S, Zendehdel K, Mazaheri Z, Muhammadnejad A, Haddadi M, ...
  • Roudkenar MH, Bahmani P, Halabian R, Mohammadi Oushandeh A, Jahanian ...
  • Sadeghi-Aliabadi H, Ahmadi A. 2003. Cytotoxicity and antitumor properties of ...
  • Sadeghi Aliabadi H, Ahmadi A. 2001. Cytotoxicity and antitumor properties ...
  • Schumacher M, Kelkel M, Dicato M, Diederich M. 2011. A ...
  • Vahabpour R, Sadat SM, Zabihollahi R, Ahmadi A, Keivani H, ...